v3.26.1
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net income $ 49,780 $ 41,171
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation 4,626 3,929
Amortization of acquisition-related intangible assets & inventory step-up 15,633 9,411
Amortization of deferred financing fees 307 322
Provision for inventory reserves 1,751 242
Provision for credit losses 188 72
Share-based compensation 4,091 4,037
Net loss on disposals of property, plant and equipment 357 0
Net pension benefit 20 17
Net deferred taxes 852 790
Changes in operating assets and liabilities:    
Accounts receivable (24,625) (7,788)
Inventories 2,170 7,641
Prepaid expenses and other current assets 7,462 656
Other assets 8 43
Accounts payable and other current liabilities 12,521 6
Retirement benefits payable and other liabilities 479 92
Net cash provided by operating activities 75,620 60,641
Cash flows from investing activities:    
Capital expenditures (6,004) (2,904)
Proceeds from sale of assets 12 0
Cash paid for acquisitions, net of cash received 0 (323,814)
Net cash used in investing activities (5,992) (326,718)
Cash flows from financing activities:    
Borrowings on line of credit 59,859 135,000
Repayments of line of credit (66,337) (40,000)
Repayments on Term Loan A (7,500) 0
Payments of deferred loan costs 0 (2,835)
Purchase of treasury shares (36,341) (9,091)
Payments of contingent consideration (113) (113)
Dividends (4,909) (4,537)
Net cash (used in) provided by financing activities (55,341) 78,424
Effect of exchange rate changes on cash and equivalents (591) (202)
Net change in cash and cash equivalents 13,696 (187,855)
Cash and cash equivalents, beginning of period 33,799 225,845
Cash and cash equivalents, end of period 47,495 37,990
Non-cash investing and financing activities:    
Capital expenditures included in accounts payable and other current liabilities $ 528 $ 436